1Jang JY, Kim SW, Park do J, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection [J]. Ann Surg, 2005; 241(1):77
2Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience[J]. AnnSurg, 2000; 232(2):166
3Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary [J]. Ann Surg Oncol, 2000; 7(1): 55
4Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study [J]. Ann Surg, 2004; 240(1):95
5Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases[J]. AnnSurg, 2003; 238(5):720
6Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma [J]. Ann Surg, 1999; 230(6):808
7Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma[J]. AnnSurg, 2001; 234(4):507
7Mei Xiao, Nin-Xing Zhou,Zhi-Qiang Huang,Ya-Li Lu, Ling-Hong Chen, Dian-Jun Wang and Wei-Lin Chang Beijing, China Department of Hepatobiliary Surgery, General Air- force of Hospital, Beijing 100036, China and General Hospital of People’ s Liberation Army, Beijing 100853 , China.The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma:a semi-quantitative study[J].Hepatobiliary & Pancreatic Diseases International,2004,3(4):599-602. 被引量：5
